Literature DB >> 17602547

Basis for design and development of platinum(IV) anticancer complexes.

Matthew D Hall1, Howard R Mellor, Richard Callaghan, Trevor W Hambley.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17602547     DOI： 10.1021/jm070280u

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  65 in total

1.  Oxidative halogenation of cisplatin and carboplatin: synthesis, spectroscopy, and crystal and molecular structures of Pt(IV) prodrugs.

Authors:  Timothy C Johnstone; Sarah M Alexander; Justin J Wilson; Stephen J Lippard
Journal:  Dalton Trans       Date:  2015-01-07       Impact factor: 4.390

2.  Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling.

Authors:  Paola Gramatica; Ester Papa; Mara Luini; Elena Monti; Marzia B Gariboldi; Mauro Ravera; Elisabetta Gabano; Luca Gaviglio; Domenico Osella
Journal:  J Biol Inorg Chem       Date:  2010-06-06       Impact factor: 3.358

3.  Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes.

Authors:  James A Platts; Giuseppe Ermondi; Giulia Caron; Mauro Ravera; Elisabetta Gabano; Luca Gaviglio; Giorgio Pelosi; Domenico Osella
Journal:  J Biol Inorg Chem       Date:  2010-11-16       Impact factor: 3.358

Review 4.  Novel metals and metal complexes as platforms for cancer therapy.

Authors:  Michael Frezza; Sarmad Hindo; Di Chen; Andrew Davenport; Sara Schmitt; Dajena Tomco; Q Ping Dou
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

5.  Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells.

Authors:  Katherine S Lovejoy; Maria Serova; Ivan Bieche; Shahin Emami; Maurizio D'Incalci; Massimo Broggini; Eugenio Erba; Christian Gespach; Esteban Cvitkovic; Sandrine Faivre; Eric Raymond; Stephen J Lippard
Journal:  Mol Cancer Ther       Date:  2011-07-12       Impact factor: 6.261

Review 6.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

7.  Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models.

Authors:  Jing Tian; Yuanzeng Min; Zachary Rodgers; Kin Man Au; C Tilden Hagan; Maofan Zhang; Kyle Roche; Feifei Yang; Kyle Wagner; Andrew Z Wang
Journal:  J Mater Chem B       Date:  2017-07-05       Impact factor: 6.331

8.  Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes.

Authors:  Matthew D Hall; Katherine A Telma; Ki-Eun Chang; Tobie D Lee; James P Madigan; John R Lloyd; Ian S Goldlust; James D Hoeschele; Michael M Gottesman
Journal:  Cancer Res       Date:  2014-05-08       Impact factor: 12.701

9.  Synthesis, characterisation and photochemistry of Pt(IV) pyridyl azido acetato complexes.

Authors:  Fiona S Mackay; Nicola J Farrer; Luca Salassa; Hui-Chung Tai; Robert J Deeth; Stephen A Moggach; Peter A Wood; Simon Parsons; Peter J Sadler
Journal:  Dalton Trans       Date:  2009-02-24       Impact factor: 4.390

10.  In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo.

Authors:  Angela Alama; Maurizio Viale; Michele Cilli; Cristina Bruzzo; Federica Novelli; Bruno Tasso; Fabio Sparatore
Journal:  Invest New Drugs       Date:  2008-06-19       Impact factor: 3.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.